Management

Government optimistic of achieving excise target

Newly-inducted Karnataka minister for excise M P Renukacharya today said that government was well on its way of meeting its excise collection target of Rs 7,000 crore for financial year 2009-2010. - "I have committed several mistakes" - Yeddyurappa expands team; inducts rebel - CM may induct dissident MLA - China"s SAIC and GM form auto JV - Maruti"s "made-in-India" car to retain Japanese touch - Maruti's US revenue zooms past Suzuki's Speaking at his maiden press conference after being sworn in as Minister, Renukacharya said it had collected Rs 4200 crore and expected to achieve its target by the end of the fiscal. He pointed out in the last two years the government had exceeded its target. The MSIL, the state"s marketing body, had taken up issuance of 463 retail licenses for liquor, indicating the government"s foray in the retail space in this category. On the issue of manufacture and sale of illicit liquor, he said 42 cells had been set up to monitor illicit liquor and to curb this menace. The total excise arrears amounted to Rs 550 crore, out of which Rs 250 crore were owed by a single institution. Renukacharya, a dissident MLA, was inducted into the Yeddyurappa Ministry on December 24, which has now snowballed into a major controversy in the ruling BJP with a section of dissidents seeking his ouster from the cabinet.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

News of the day
BSNL FY09 net dips at Rs 104 cr as wage rises, revenue falls
State-run Bharat Sanchar Nigam"s (BSNL) net profit dipped to Rs 104 crore in 2008-09 as staff costs rose and revenues fell in the period, Rajya Sabha was informed today.
Popular Articles
payday loans online

ONGC strengthens ethical practices
The public sector Oil & Natural Gas Corporation (ONGC) has cleared the ground for implementing “whistle blower policy” another major voluntary initiative to promote transparency and ethics in personal conduct and decision process.
Polygraphy
AstraZeneca, Nektar Therapeutics sign license agreement
AstraZeneca, an international healthcare company engaged in research, development and manufacturing of prescription medicines, and Nektar Therapeutics, a biopharmaceutical company headquartered at California with research and development operations in Hyderabad, have entered into an exclusive license agreement for two drug development programmes.